期刊文献+

乳腺癌癌周微脉管密度与其临床病理特征的相关性研究 被引量:3

Correlationship Between the Peritumor Microvessel Density and Pathological Features in Breast Cancer
暂未订购
导出
摘要 目的 探讨微脉管密度 (TMVD )、微血管密度 (BMVD)、微淋巴管密度 (LMVD )与乳腺癌临床病理特征的关系。方法 选取 80例临床病理资料完整的乳腺癌组织 ,应用免疫组化双染试剂盒 (Histostain DS试剂盒 )、FVⅢ RA单克隆抗体和Ⅳ型胶原单克隆抗体 ,在同一张组织切片上分别对内皮细胞和基膜进行标记 ,在光镜下分别观察微脉管密度、微血管密度和微淋巴管密度。结果 微脉管密度在腋窝淋巴结阴性组和淋巴结转移 1~ 3个组、4~ 9个组、10个以上组分别为 3 5 .64± 9.2 8,45 .47± 7.60 ,5 7.0 0± 9.17,67.0 0± 9.5 6;微血管密度在以上各组分别为 2 3 .3 6± 7.0 6,3 0 .5 3± 6.13 ,3 8.40± 6.67,43 .75± 6.85 ;微淋巴管密度在以上各组分别为 12 .2 7± 2 .49,14 .93± 2 .46,18.60± 2 .76,2 3 .2 5± 3 .40。微脉管密度、微血管密度和微淋巴管密度均与腋窝淋巴结状态呈显著正相关 (P <0 .0 5 ) ,随腋窝淋巴结转移数目的增加而增大 ;而三者与肿瘤大小、病理类型、组织分化程度、绝经状态以及雌激素受体状况等因素均无相关性 (P >0 .0 5 )。结论 微脉管密度、微血管密度、微淋巴管密度与乳腺癌腋窝淋巴结状态密切相关 。 Objective To investigate the relationship between lymphatic microvessel density,blood microvessel density and breast cancer′s clinical and pathological features.Methods The data of 80 cases of breast cancer were collected.Two monocolonal antibodies,anti-FVⅢ-RA monocolonal antibody and anti-collagen Ⅳ monocolonal antibody were used to mark endotheliocyte and basement membrane.Then the peritumor lymphatic microvessel density(LMVD),blood microvessel density(BMVD)and total microvessel density(TMVD)were observed under microscope.Results TMVD was 35.64±9.28 in patients without lymph node metastasis,45.47±7.60,57.00±9.17 and 67.00±9.56 in patients with 1~3,4~9,and ≥10 axillary lymph nodes metastasis,respectively.BMVD was 23.36±7.06,30.53±6.13,38.40±6.67 and 43.75±6.85 in the above four groups,respectively.LMVD was 12.27±2.49,14.93±2.46,18.60±2.76,23.25±3.40 in the above four groups,respectively.LMVD,BMVD and TMVD had significantly positive correlation with the status of axillary lymph node(P<0.05),but had no correlation with the size,pathological type of tumor,differentiation degree,and status of estrogen receptor et al(P>0.05).Conclusion TMVD,BMVD and LMVD are important indicators to evaluate the status of axillary lymph node of breast cancer.
出处 《实用癌症杂志》 2004年第2期144-147,共4页 The Practical Journal of Cancer
关键词 乳腺癌 癌周组织 微血管密度 病理特征 相关性 肿瘤转移 Breast cancer Peritumor Total microvessel density Clinical and pathological features Status of axillary lymph node
  • 相关文献

参考文献9

  • 1Yonemura Y, Endo Y,Fujita H, et al. Rode of vascular endothelial growth factor-c expression in the development of lymph node metastasis in gastric cancer[J ]. Clin Cancer Res, 1999,5(8): 1823.
  • 2Tsarnsaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-c expression in human prostatic carcinomaand its relationship to lymph node metastasis [ J ]. Br J Cancer, 1999,80(2): 309.
  • 3Zotota V,Gerokosta A,Melachrinou M,et al. Microvessel density,proliferating activity, p53 and bcl-2 expression in situ ductal carcinoma of the breast [J ]. Anticancer Res,1999,19(4) : 3269.
  • 4Basari S, Delellis RA, Healtley GJ. Microvessel quantitation and prognosis in invasive breast carcinoma [J ]. Hum Pathol, 1992,23 (6): 755.
  • 5Noel Weidner,Judah Folkman,Franco Pozza,et al. Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma [J ]. JNCI, 1992,84(10): 1875.
  • 6Miliaras D, Kamas A, Kalekow H. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? [ J ]. Histopathology, 1995, 26(1) :165.
  • 7Martin L, Holcombe C, Renshaw C, et al. Standardising the counting technique of neovascularization in invasive breast cancer[J ]. Breast Cancer Res Treat, 1996,37(1 ):34.
  • 8Toi M, Inada K, Suzuki H, et al. Tumor angiogenesis in breast cancer:its importance as a prognostic indicator and the association with vascular endothelial growth factor expression[J]. Breast Cancer Res Treat, 1995,36(2):193.
  • 9Ohta Y,Shridhar V,Bright RK,et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumors [J ]. Br J Cancer, 1999,81(1): 54.

同被引文献47

  • 1王天宝,董文广,韩方海,李兆亭.血管内皮生长因子受体-3与胃癌临床病理因素的关系[J].中国普外基础与临床杂志,2004,11(4):341-343. 被引量:5
  • 2梁后杰,彭亦良.肿瘤淋巴管生成与肿瘤淋巴道转移研究进展[J].武警医学,2005,16(5):323-325. 被引量:3
  • 3厉红元.肿瘤的血管形成及对乳腺癌预后的评价[J].中国肿瘤临床,1997,24(3):218-222. 被引量:4
  • 4Enholm B,Jussila L,Karkkainen M,et al.Vascular endothelial growth factor-C:a growth factor for lymphatic and blood vascularendothelial cells[J].Trends Cardiovasc Med,1998,8(7)∶292-295.
  • 5Yonmura Y,Fushida S,Bando E,et al.Lymphangiogenesis and the vascular endothelial growth factor receptor(VEGFR)-3 in gastric cancer[J].Eur J Cancer,2001,37:918-923.
  • 6Weidner N,Folkman J,Pozza F,et al.Tumor Angiogenesis:answer ignificant and independent prognostic in dicator in early stage breast carcinoma[J].J Nati Cancer Inst,1992,84:1875-1887.
  • 7王忠裕.胃十二指肠疾病[M].陈孝平.外科学.人民卫生出版社,2002:574-576.
  • 8Brown LF,Detmar M,Claffey K,et al.Vasclular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine[J].Exs,1997,79:233.
  • 9Lohela M,Saaristo A,Veikkola T,et al.Lymphangiogenic growth factors,receptors and therapies[J].Thromb Haemost,2003,90(2):167-184.
  • 10Stacker SA,Hughes RA,Achen MG.Molecular targeting of lymphatics for therapy[J].Curr Pharm Des,2004,10(1):65-74.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部